ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Companies

Fujifilm's Komori to step down as chairman

81-year-old turned photo film giant into medical equipment supplier

Shigetaka Komori, chairman and CEO Fujifilm, will retire later this year. (File photo by Takaki Kashiwabara)

TOKYO -- Shigetaka Komori, the man who steered Japan's Fujifilm Holdings through the decline of the photo film industry and transformed it into a medical and office equipment maker, will step down as chairman after leading the company for 20 years, Nikkei has learned.

His retirement will be confirmed following the general shareholders meeting in June, after which he will serve as the company's chief adviser.

Kenji Sukeno, the company's current president and chief operating officer, will be appointed chairman, and Teiichi Goto will take over as president and CEO.

Komori, now 81, was appointed president of Fujifilm in 2000, when the manufacturer was hit hard by shrinking demand for photographic film due to the growing popularity of digital cameras.

Fujifilm moved into the pharmaceutical market in 2008 after acquiring Toyama Chemical, and the company reinforced its medical business through the purchase of Wako Pure Chemical Industries in 2017.

Komori became chairman in 2012 and for the last five years has managed the company alongside Sukeno, who became president in 2016.

The group forecasts its consolidated net income will reach a record-high in the fiscal year ending March 2021, on the back of a strong performance by its biopharmaceutical business.

Goto, the incoming president, is currently in charge of the medical devices business and led negotiations to acquire the diagnostic imaging equipment business from Hitachi. As president, he will accelerate the expansion of Fujifilm's health care and overseas operations.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends July 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more